The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

Our objective was to determine: 1) whether the checkpoint kinase 2 (CHEK2) del5395 (g.27417113-27422508 del, NC_000022.11) is a founder mutation in the Latvian population, 2) if there is an association between CHEK2 del5395 mutation and cancer risk, and 3) and whether the CHEK2 del5395 mutation impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Plonis, J, Kalniete, D, Nakazawa-Miklasevica, M, Irmejs, A, Vjaters, E, Gardovskis, J, Miklasevics, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026266/
https://www.ncbi.nlm.nih.gov/pubmed/27785394
http://dx.doi.org/10.1515/bjmg-2015-0083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026266/
https://www.ncbi.nlm.nih.gov/pubmed/27785394
http://dx.doi.org/10.1515/bjmg-2015-0083

Ejemplares similares